The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-12 2024 | The ethnic diversity in the presentation and outcome of WM and MGUS in the United Kingdom
Shirley D’Sa, MD, FRCP, FRCPath, University College London, London, United Kingdom, discusses a study investigating the ethnic diversity in the presentation and outcome of Waldenström’s macroglobulinemia (WM) and monoclonal gammopathy of undetermined significance (MGUS) in the United Kingdom. The findings revealed diversity in the biological characteristics of patients from ethnic minorities compared to white patients, as well as differences dependent on social deprivation. This interview took place at the 12th International Workshop on Waldenström’s Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
